Healthcare & Life Scienceshttps://www.bakermckenzie.com/en/rss-landing/industries/healthcareHealthcare & Life Sciencesen{151CDB2F-27F1-4270-A035-925AD340CA14}https://www.bakermckenzie.com/en/newsroom/2026/04/merit-medical-acquires-view-point-medicalTransactionsMergers & AcquisitionsHealthcare & Life SciencesLife Sciences TransactionsMedical DevicesBaker McKenzie Advises Merit Medical on the Acquisition of View Point MedicalTue, 07 Apr 2026 00:00:00 Z{E70B46C7-959F-4516-B6F0-DB2017A2B5BA}https://www.bakermckenzie.com/en/newsroom/2026/04/baker-mckenzie-advises-consortium-led-by-spe-capitalMergers & AcquisitionsHealthcare & Life SciencesBaker McKenzie Advises a Consortium led by SPE Capital, and included EBRD, Proparco and BIO on their Investment in Leading Ophthalmic Pharmaceutical ManufacturerWed, 01 Apr 2026 00:00:00 Z{FEB43FDA-C249-4E90-9AA5-50F1AD528082}https://www.bakermckenzie.com/en/insight/publications/2026/03/singapore-hsa-attains-highest-who-certificationSingaporeHealthcare & Life SciencesSingapore: HSA Attains Highest WHO CertificationTue, 31 Mar 2026 00:00:00 Z{8A20767D-3FBC-432A-9CF1-1EC1BBBCEFD8}https://www.bakermckenzie.com/en/insight/publications/2026/03/singapore-moh-and-hsa-launch-refreshed-ai-in-healthcare-guidelinesSingaporeHealthcare & Life SciencesSingapore: MOH and HSA Launch Refreshed AI in Healthcare GuidelinesTue, 31 Mar 2026 00:00:00 Z{3BAE3CF2-649E-4A6B-B676-E4D66802662C}https://www.bakermckenzie.com/en/insight/publications/2026/03/singapore-revisions-to-the-sapi-code-from-march-2026SingaporeHealthcare & Life SciencesSingapore: Revisions to the SAPI Code from March 2026Tue, 31 Mar 2026 00:00:00 Z{A81A5820-E14D-4B16-8658-8AD5E54C0916}https://www.bakermckenzie.com/en/insight/publications/2026/03/united-states-trump-launches-nationwide-antifraud-task-forceInvestigations, Compliance & EthicsDispute ResolutionHealthcare & Life SciencesUnited States Administration Launches Nationwide Anti‑Fraud Task ForceThu, 26 Mar 2026 00:00:00 Z{0F28D790-7CAC-409A-858F-BFE1C6573B2B}https://www.bakermckenzie.com/en/newsroom/2026/03/sunway-healthcare-ipoSingaporeLondonCapital MarketsHealthcare & Life SciencesFinancial InstitutionsEquity & Debt TransactionsTransactionsBaker McKenzie Advises Joint Bookrunners on Sunway Healthcare’s MYR 3.28 Billion IPOWed, 18 Mar 2026 00:00:00 Z{357FD6D6-AC7E-4547-B145-D8FABD7A57B6}https://www.bakermckenzie.com/en/newsroom/2026/03/sino-biopharm-exclusive-license-agreementHong KongAntitrust & CompetitionMergers & AcquisitionsPrivate EquityHealthcare & Life SciencesIntellectual PropertyBaker McKenzie Advises Sino Biopharm on up to US$1.53 Billion Exclusive License Agreement with Sanofi for RovadicitinibThu, 12 Mar 2026 00:00:00 Z{18E19B63-E5E8-4526-8A2D-0AAEE633CAB7}https://www.bakermckenzie.com/en/newsroom/2026/03/medtronic-carve-out-and-spinoff-of-minimedMergers & AcquisitionsCarve-outsCorporate ReorganizationsHealthcare & Life SciencesEmployment & CompensationAntitrust & CompetitionIntellectual PropertyTaxBaker McKenzie Acts as Global Counsel to Medtronic plc on the Carve-out and Spin-off of their Diabetes business, MiniMed Group, Inc. Wed, 11 Mar 2026 00:00:00 Z{A925B80F-DBC7-4E49-BDFC-EA145A42D4FD}https://www.bakermckenzie.com/en/newsroom/2026/03/servier-acquisition-day-one-biopharmaceuticalsTransactionsMergers & AcquisitionsHealthcare & Life SciencesBaker McKenzie Advises Servier on the Acquisition of Day One Biopharmaceuticals for Approximately USD 2.5 BillionTue, 10 Mar 2026 00:00:00 Z{961A8786-6EAF-459F-9C92-D10EFE44135A}https://www.bakermckenzie.com/en/insight/publications/guides/ukrainian-laws-in-wartimeKyivHealthcare & Life SciencesBanking & FinanceEmployment & CompensationTaxReal EstateIntellectual PropertyAntitrust & CompetitionFinancial InstitutionsUkrainian Laws in WartimeWed, 04 Mar 2026 00:00:00 Z{64B5E651-BAC3-40C3-B7F9-30D3E92AD813}https://www.bakermckenzie.com/en/insight/publications/2026/02/singapore-hsa-releases-ai-medical-softwareSingaporeHealthcare & Life SciencesSingapore: HSA Releases AI Medical Software Consultation FindingsFri, 27 Feb 2026 00:00:00 Z{33964808-3C8E-4F64-8BF3-2D1AF67942C6}https://www.bakermckenzie.com/en/insight/publications/2026/02/singapore-hsa-updates-defect-reportingSingaporeHealthcare & Life SciencesSingapore: HSA Updates Defect Reporting and Recall GuidanceFri, 27 Feb 2026 00:00:00 Z{B38953C7-9122-457D-BE96-ABC5BF00779D}https://www.bakermckenzie.com/en/insight/publications/2026/02/how-does-indias-union-budget-apply-to-your-strategic-growth-plansMergers & AcquisitionsInternational Commercial & TradeData, Technology, Privacy & CybersecurityTaxHealthcare & Life SciencesEnergy & InfrastructureIndustrials, Manufacturing & TransportationEnergy & InfrastructureHow Does India's Union Budget Apply to Your Strategic Growth Plans?Tue, 10 Feb 2026 00:00:00 Z{D4563EBD-6676-4FA1-8524-2C4C68776764}https://www.bakermckenzie.com/en/insight/publications/2026/02/south-africa-who-2025-global-tax-reportsJohannesburgTaxHealthcare & Life SciencesSouth Africa: WHO 2025 Global Tax ReportsMon, 09 Feb 2026 00:00:00 Z{B8C34CC3-84D6-403F-BFCC-D2B2D1408C2B}https://www.bakermckenzie.com/en/insight/publications/2026/02/vietnam-new-circular-enhances-customs-ip-enforcementHanoiHo Chi Minh CityIntellectual PropertyHealthcare & Life SciencesConsumer Goods & RetailVietnam: New Circular Enhances Customs IP EnforcementThu, 05 Feb 2026 00:00:00 Z{B8BB79AD-B988-4B8A-BA41-7AE5A8BE1529}https://www.bakermckenzie.com/en/insight/publications/2026/01/singapore-regulatory-updates-for-therapeutic-product-registrationSingaporeHealthcare & Life SciencesSingapore: Regulatory Updates for Therapeutic Product RegistrationThu, 29 Jan 2026 00:00:00 Z{DA122FAF-F97D-452D-AB6F-17567F7E681B}https://www.bakermckenzie.com/en/insight/publications/2026/01/singapore-health-information-bill-passed-in-parliamentSingaporeHealthcare & Life SciencesSingapore: Health Information Bill Passed in ParliamentThu, 29 Jan 2026 00:00:00 Z{0CD74C76-17A5-404F-8BB0-BA6AAEAF225F}https://www.bakermckenzie.com/en/insight/publications/2026/01/united-states-the-biosecure-act-becomes-lawHealthcare & Life SciencesInternational Commercial & TradeUnited States: The BIOSECURE Act Becomes LawMon, 19 Jan 2026 00:00:00 Z{99224EBE-FD43-4709-8A31-A8E28D2F3C5E}https://www.bakermckenzie.com/en/insight/publications/2026/01/international-manufacturing-site-divestituresMergers & AcquisitionsHealthcare & Life SciencesSupply ChainsInternational: Manufacturing Site DivestituresFri, 09 Jan 2026 00:00:00 Z{DAA70CFE-085B-4947-96CD-630D0375257E}https://www.bakermckenzie.com/en/newsroom/2026/01/acquisition-of-iq-messengerMergers & AcquisitionsBanking & FinanceData, Technology, Privacy & CybersecurityEmployment & CompensationHealthcare & Life SciencesIntellectual PropertyPrivate EquityReal EstateBaker McKenzie advises Main Capital Partners on the acquisition of IQ MessengerThu, 08 Jan 2026 00:00:00 Z{9E6EDE98-1202-4F37-837D-AB2890518DFC}https://www.bakermckenzie.com/en/newsroom/2025/12/chambers-asia-pacific-2026Banking & FinanceIntellectual PropertyData, Technology, Privacy & CybersecurityFunds & Investment ManagementPrivate EquityHealthcare & Life SciencesTechnologyIslamic FinanceMergers & AcquisitionsDispute ResolutionEmployment & CompensationEnergy & InfrastructureTaxReal EstateInternational Commercial & TradeAviation, Aerospace & DefenseCapital MarketsAntitrust & CompetitionInsuranceBaker McKenzie Earns 149 Practice and 226 Individual Rankings in Chambers Asia Pacific 2026Fri, 12 Dec 2025 00:00:00 Z{3973206B-C676-4971-841B-2E7A9219BBFB}https://www.bakermckenzie.com/en/newsroom/2025/11/sale-of-citieffe-group-to-polymedZurichMergers & AcquisitionsTaxDispute ResolutionInternational Commercial & TradeHealthcare & Life SciencesMedical DevicesBaker McKenzie Advises Current Shareholders (Including Funds Advised by ARCHIMED as Controlling Shareholder) on the Sale of Citieffe Group to PolyMedTue, 25 Nov 2025 00:00:00 Z{EC38002C-BDF2-409C-9B82-0736D7EB433A}https://www.bakermckenzie.com/en/newsroom/2025/11/fierce-biotech-jefferies-conferenceBanking & FinanceCapital MarketsMergers & AcquisitionsHealthcare & Life SciencesJane Hobson and Roel Meers Provide Insights to Fierce Biotech During Jefferies Global Healthcare ConferenceTue, 25 Nov 2025 00:00:00 Z{AC57345E-47D8-446D-B109-464B6D2350D4}https://www.bakermckenzie.com/en/insight/publications/2025/11/opportunities-for-innovators-investors-strategic-partnersData, Technology, Privacy & CybersecurityDispute ResolutionEmployment & CompensationInternational Commercial & TradeMergers & AcquisitionsHealthcare & Life SciencesMedical DevicesPharmaceuticals & BiotechTransactional IPSupply ChainsOpportunities for Innovators, Investors and Strategic PartnersThu, 06 Nov 2025 00:00:00 Z{DFAE93B8-3FB1-4964-8F05-004C787979A1}https://www.bakermckenzie.com/en/newsroom/2025/10/keensight-capital-acquisition-majority-stake-bedfont-scientificLondonBanking & FinancePrivate EquityHealthcare & Life SciencesBaker McKenzie advises on Keensight Capital’s acquisition of a majority stake in Bedfont Scientific Ltd.Fri, 31 Oct 2025 00:00:00 Z{F8907BDB-CFEC-4462-8182-82A2A2DE3821}https://www.bakermckenzie.com/en/newsroom/2025/10/takeda-partners-with-innovent-biologicsTransactionsLife Sciences TransactionsHealthcare & Life SciencesPharmaceuticals & BiotechBaker McKenzie Advises Takeda in Global Strategic Collaboration with Innovent BiologicsWed, 22 Oct 2025 00:00:00 Z{B3F17A34-6211-46CB-9EF6-F12A7E8FF71E}https://www.bakermckenzie.com/en/newsroom/2025/10/lotus-pharmaceutical-acquisition-of-alvogen-usTaipeiTransactionsMergers & AcquisitionsHealthcare & Life SciencesLife Sciences TransactionsBaker McKenzie Advises Lotus Pharmaceutical in Acquisition of Alvogen USFri, 17 Oct 2025 00:00:00 Z{4E0B2106-2291-4E9A-A042-05C791D2DEEC}https://www.bakermckenzie.com/en/insight/publications/2025/10/achieving-stability-through-innovation-complianceHealthcare & Life SciencesPharmaceuticals & BiotechMedical DevicesSupply ChainsInternational Commercial & TradeMergers & AcquisitionsDispute ResolutionData, Technology, Privacy & CybersecurityTransactional IPEmployment & CompensationAchieving Stability Through Innovation and ComplianceMon, 06 Oct 2025 00:00:00 Z{873F3A60-287B-4673-800A-E652A8B20B4B}https://www.bakermckenzie.com/en/insight/publications/guides/guide-to-ipos-for-biotech-and-pharma-companiesCapital MarketsHealthcare & Life SciencesPharmaceuticals & BiotechLife Sciences TransactionsDigital HealthGuide to IPOs for Biotech and Pharma CompaniesMon, 29 Sep 2025 00:00:00 Z{CF8523D5-0AD5-4CD8-A100-BACB7244EB23}https://www.bakermckenzie.com/en/newsroom/2025/09/cslLondonAmsterdamBrusselsWashington, DCAntitrust & CompetitionEmployment & CompensationIntellectual PropertyMergers & AcquisitionsTaxHealthcare & Life SciencesBaker McKenzie advises CSL on its strategic collaboration with VarmXFri, 19 Sep 2025 00:00:00 Z{A5C11850-E283-4082-A476-052BE61959E8}https://www.bakermckenzie.com/en/newsroom/2025/09/servierParisLondonMergers & AcquisitionsTaxPharmaceuticals & BiotechLife Sciences TransactionsHealthcare & Life SciencesBaker McKenzie advises Servier on the acquisition of a potential treatment for Fragile X syndromeThu, 18 Sep 2025 00:00:00 Z{724A1196-F118-4159-9098-FDAB2FC3F954}https://www.bakermckenzie.com/en/insight/publications/guides/doing-business-in-the-united-arab-emiratesAbu DhabiDubaiAntitrust & CompetitionBanking & FinanceData, Technology, Privacy & CybersecurityDispute ResolutionEmployment & CompensationMergers & AcquisitionsIntellectual PropertyInternational Commercial & TradeFinancial InstitutionsTechnologyHealthcare & Life SciencesInternational ArbitrationFinancial Services RegulatoryVAT / Indirect TaxTaxOnline Services/PlatformsIT Services and ConsultingTechnology Devices & EquipmentDoing Business in the United Arab Emirates 2025Tue, 16 Sep 2025 00:00:00 Z{83656965-9EF0-4F91-ADA8-E66EEBCBA510}https://www.bakermckenzie.com/en/newsroom/2025/09/medexpert-integration-into-msa-mizarMergers & AcquisitionsHealthcare & Life SciencesBaker McKenzie Advises Medexpert on Its Integration Into MSA MizarMon, 08 Sep 2025 00:00:00 Z{F1BF335F-3F88-4A37-8D0B-9E4A0E35376C}https://www.bakermckenzie.com/en/insight/publications/2025/09/trade-winds-tariffs-optimizing-operationsHealthcare & Life SciencesInternational Commercial & TradePharmaceuticals & BiotechMedical DevicesSupply ChainsTaxDispute ResolutionMergers & AcquisitionsTrade Winds, Tariffs, and Optimizing OperationsWed, 03 Sep 2025 00:00:00 Z{1E5FD4CC-0A52-4D59-ACC7-CBC6CCBECF20}https://www.bakermckenzie.com/en/newsroom/2025/08/swiss-cardio-technologies-sells-to-abacus-medicineMergers & AcquisitionsHealthcare & Life SciencesPharmaceuticals & BiotechLife Sciences TransactionsBaker McKenzie Advises the Shareholders of Swiss Cardio Technologies AG on their Sale to Abacus Medicine GroupThu, 28 Aug 2025 00:00:00 Z{9B5554A3-4392-4365-933A-F96FC7C90FEA}https://www.bakermckenzie.com/en/newsroom/2025/08/bayer-and-kumquat-collaborationAntitrust & CompetitionMergers & AcquisitionsPharmaceuticals & BiotechHealthcare & Life SciencesLife Sciences TransactionsBaker McKenzie Advises Bayer on Antitrust Aspects of Global License and Collaboration with Kumquat Biosciences Tue, 26 Aug 2025 00:00:00 Z{12970095-6629-429F-AD46-DB18CC917021}https://www.bakermckenzie.com/en/newsroom/2025/08/chambers-latin-america-2026-guideBanking & FinanceCapital MarketsAntitrust & CompetitionMergers & AcquisitionsData, Technology, Privacy & CybersecurityDispute ResolutionEnvironment & Climate ChangeEnergy & InfrastructureIntellectual PropertyInternational Commercial & TradeEmployment & CompensationTaxHealthcare & Life SciencesTechnologyProject FinancePublic Law & Regulatory DisputesBaker McKenzie Earns Top Rankings in Chambers Latin America 2026 GuideFri, 22 Aug 2025 00:00:00 Z{FD7E9576-8C76-4C52-8956-A145DACBB927}https://www.bakermckenzie.com/en/newsroom/2025/08/piotr-korzynski-named-life-sciences-m-and-a-rising-starMergers & AcquisitionsLife Sciences TransactionsHealthcare & Life SciencesBaker McKenzie’s Piotr Korzynski Named a Life Sciences M&A Rising Star by Law360Thu, 07 Aug 2025 00:00:00 Z{A9CDD9C1-5123-4680-A5BC-9602687CDDD9}https://www.bakermckenzie.com/en/insight/publications/2025/08/uk-government-policy-implementation-trackerLondonConsumer Goods & RetailFinancial InstitutionsHealthcare & Life SciencesIndustrials, Manufacturing & TransportationEmployment & CompensationEnergy & InfrastructureInvestigations, Compliance & EthicsIT Services and ConsultingOnline Services/PlatformsPensionsPublic Law & Regulatory DisputesTaxTechnologyTechnology Devices & EquipmentWealth ManagementEnergy & InfrastructureUK Government Policy Implementation Tracker 2025Tue, 05 Aug 2025 00:00:00 Z{8A855BD1-C248-4B06-B236-1B2E0B089414}https://www.bakermckenzie.com/en/insight/publications/resources/business-impact-of-new-us-administrationAntitrust & CompetitionInternational Commercial & TradeTaxTechnologyHealthcare & Life SciencesEmployment & CompensationGlobal Immigration & MobilityOnline Services/PlatformsIT Services and ConsultingInclusion, Diversity & EquityTechnology Devices & EquipmentConsumer HealthcareLooking Ahead: Cross-Border Strategies Amid US Policy ShiftsThu, 31 Jul 2025 00:00:00 Z{085139DF-4FC7-48E5-BCE0-12FB775D5661}https://www.bakermckenzie.com/en/insight/publications/2025/07/strategic-decisions-business-continuityHealthcare & Life SciencesSupply ChainsInternational Commercial & TradeMergers & AcquisitionsPharmaceuticals & BiotechMedical DevicesLife Sciences TransactionsStrategic Decisions for Business ContinuityWed, 30 Jul 2025 00:00:00 Z{1BD229A3-F6BC-4EE6-94BE-21FDBFE3922E}https://www.bakermckenzie.com/en/insight/publications/2025/07/eu-restricts-chinese-medical-devices-to-the-euro-marketHealthcare & Life SciencesMedical DevicesEU Restricts Access of Chinese Medical Devices to the European MarketTue, 15 Jul 2025 00:00:00 Z{87A91F19-6DFC-4980-B54E-25A4E3637366}https://www.bakermckenzie.com/en/newsroom/2025/06/global-digital-delivery-alliance-eventTaipeiData, Technology, Privacy & CybersecurityHealthcare & Life SciencesIndustrials, Manufacturing & TransportationBaker McKenzie Taipei Speaks at Global Digital Delivery Alliance Event on Emerging Trends in CybersecurityMon, 16 Jun 2025 00:00:00 Z{9268DA21-AF20-467C-AF67-747EB1BE551F}https://www.bakermckenzie.com/en/newsroom/2025/06/taiwan-law-firm-of-the-yearAntitrust & CompetitionBanking & FinanceDispute ResolutionEmployment & CompensationIntellectual PropertyInternational Commercial & TradeArtificial IntelligenceData, Technology, Privacy & CybersecurityEnergy & InfrastructureSustainability and ESGTransactionsWorkforce RedesignIndustrials, Manufacturing & TransportationTechnologyInvestigations, Compliance & EthicsConsumer Goods & RetailHealthcare & Life SciencesBaker McKenzie Taipei Wins Second Consecutive 'Taiwan Law Firm of the Year' on 50th AnniversaryFri, 06 Jun 2025 00:00:00 Z{D6074B11-9BCD-4CBB-BE87-8349EDF8FD64}https://www.bakermckenzie.com/en/newsroom/2025/06/us-bond-offering-for-teva-pharmaceuticalLondonAmsterdamWashington, DCNew YorkLos AngelesHoustonCapital MarketsHealthcare & Life SciencesLife Sciences TransactionsBaker McKenzie Advises on USD 2.3 Billion Bond Offering for Teva Pharmaceutical and Concurrent Tender OfferThu, 05 Jun 2025 00:00:00 Z{9AE66D6F-0F0D-4B54-AD5E-BBF0384DE152}https://www.bakermckenzie.com/en/newsroom/2025/06/chambers-usaAntitrust & CompetitionArtificial IntelligenceConsumer Goods & RetailData, Technology, Privacy & CybersecurityDispute ResolutionEmployment & CompensationEnergy TransitionEnvironment & Climate ChangeHealthcare & Life SciencesIndustrials, Manufacturing & TransportationIntellectual PropertyInternational Commercial & TradeInvestigations, Compliance & EthicsMergers & AcquisitionsPrivate EquityReal EstateRestructuring & InsolvencyTaxBaker McKenzie Earns 53 Practice and Sector Area Rankings and 96 Lawyer Rankings in Chambers USA 2025 GuideThu, 05 Jun 2025 00:00:00 Z{98AFB51B-1474-4877-BD68-E417BCE1E403}https://www.bakermckenzie.com/en/newsroom/2025/06/deal-digest-march-april-may-2025Banking & FinanceCapital MarketsConsumer Goods & RetailEnergy & InfrastructureEnergy TransitionFinancial InstitutionsHealthcare & Life SciencesIndustrials, Manufacturing & TransportationMergers & AcquisitionsPrivate EquitySustainability and ESGTax for M&A and ReorganizationsTech M&A TransactionsTechnologyDeal Digest – March, April, May 2025Wed, 04 Jun 2025 00:00:00 Z{B2F17BCB-79FF-4594-A5C4-04A5DBF28FAB}https://www.bakermckenzie.com/en/newsroom/2025/05/docmorris-chf-208m-rights-offeringCapital MarketsTaxMarketing, Regulatory & PublicHealthcare & Life SciencesLife Sciences TransactionsBaker McKenzie Advises DocMorris on CHF 208 Million Rights OfferingMon, 26 May 2025 00:00:00 Z{BCEED287-A8FE-4300-AC84-3C9C86CC7527}https://www.bakermckenzie.com/en/newsroom/2025/05/mirxes-ipoHong KongBanksCapital MarketsFinancial InstitutionsTransactionsHealthcare & Life SciencesEquity & Debt TransactionsBaker McKenzie Acts for Joint Sponsors and Underwriters in Mirxes' Global Offering and Hong Kong IPOFri, 23 May 2025 00:00:00 Z